Fernandes, B.; Castro, R.; Bhoelan, F.; Bemelman, D.; Gomes, R.A.; Costa, J.; Gomes-Alves, P.; Stegmann, T.; Amacker, M.; Alves, P.M.;
et al. Insect Cells for High-Yield Production of SARS-CoV-2 Spike Protein: Building a Virosome-Based COVID-19 Vaccine Candidate. Pharmaceutics 2022, 14, 854.
https://doi.org/10.3390/pharmaceutics14040854
AMA Style
Fernandes B, Castro R, Bhoelan F, Bemelman D, Gomes RA, Costa J, Gomes-Alves P, Stegmann T, Amacker M, Alves PM,
et al. Insect Cells for High-Yield Production of SARS-CoV-2 Spike Protein: Building a Virosome-Based COVID-19 Vaccine Candidate. Pharmaceutics. 2022; 14(4):854.
https://doi.org/10.3390/pharmaceutics14040854
Chicago/Turabian Style
Fernandes, Bárbara, Rute Castro, Farien Bhoelan, Denzel Bemelman, Ricardo A. Gomes, Júlia Costa, PatrÃcia Gomes-Alves, Toon Stegmann, Mario Amacker, Paula M. Alves,
and et al. 2022. "Insect Cells for High-Yield Production of SARS-CoV-2 Spike Protein: Building a Virosome-Based COVID-19 Vaccine Candidate" Pharmaceutics 14, no. 4: 854.
https://doi.org/10.3390/pharmaceutics14040854
APA Style
Fernandes, B., Castro, R., Bhoelan, F., Bemelman, D., Gomes, R. A., Costa, J., Gomes-Alves, P., Stegmann, T., Amacker, M., Alves, P. M., Fleury, S., & Roldão, A.
(2022). Insect Cells for High-Yield Production of SARS-CoV-2 Spike Protein: Building a Virosome-Based COVID-19 Vaccine Candidate. Pharmaceutics, 14(4), 854.
https://doi.org/10.3390/pharmaceutics14040854
